Topic:
Partnering
Latest Headlines
Latest Headlines
Vectura joins forces with a new JV biotech in China for respiratory therapies
The U.K.'s Vectura has thrown its dry powder inhaler technology into a newly established Chinese joint venture biotech that is setting out to develop and commercialize new respiratory treatments for a growing Asian market.
Argentine CRO Stat Research taps Datatrak
Stat Research, a Buenos Aires-based CRO, has reached out to eClinical provider Datatrak in an effort to reduce clinical trial costs and accelerate drug development timelines.
GSK signs up with DKSH to tap Hong Kong market
GlaxoSmithKline is turning to market-expansion contractors DKSH to push its antibiotic products in Hong Kong, part of the drugmaker's efforts to cash in on booming Asian demand.
Bristol-Myers Squibb pursues cancer biomarker development deal
Bristol-Myers Squibb will collaborate with Adaptive Biotechnologies to develop immunological biomarkers for cancer, representing another step forward in the development of personalized medicine.
UPDATED: Elan pays $1B for a slice of Theravance's COPD franchise royalty stream
Elan has struck a deal to pay a billion dollars for a share of Theravance's future royalties on Breo and a slate of other respiratory drugs now in development, announcing the deal right on the heels of Breo's approval in the U.S. on Friday.
Trevena lands $430M Forest deal, $60M venture round as heart drug heads to PhIIb
With its lead drug poised to begin a Phase IIb study for acute heart failure, Trevena grabbed a $30 million investment from Forest Laboratories, which also picked up an option to snag global rights to the biotech's lead therapy with a deal that includes a $430 million potential payout.
Shire strikes discovery deal in rare diseases with Bill Gates-backed Nimbus
Shire has nailed down another deal to fuel its growing rare disease unit. The pharma group has tapped the Cambridge, MA-based startup Nimbus Discovery, which will use its computational approach to find small-molecule drugs for rare genetic diseases known as lysosomal storage disorders.
Eli Lilly, Insulet to develop Humulin-specific OmniPod
Insulet, creator of the OmniPod tubeless insulin pump, joined forces with Eli Lilly this week to develop a new version of the device designed to deliver Lilly's Humulin R U-500 insulin.
Bristol-Myers' 'smart bomb' deal pushes Ambrx 12-month deal tally to $715M
Just a month after landing a $15 million payday for a deal with Astellas to collaborate on new antibody drug conjugates for cancer, the San Diego-based biotech Ambrx has scored another research pact--reaping another $15 million upfront from Bristol-Myers in exchange for a new oncology partnership.
Merck buddies up to Scripps spinout Abide in $430M diabetes partnership
Yesterday Merck's top executives spent a considerable amount of time trying to reassure analysts that the Big Pharma company is actively engaged in the hunt for new drugs needed to beef up a weak pipeline.
